These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2754556)

  • 1. Familial concordance of pancreatic function in cystic fibrosis.
    Corey M; Durie P; Moore D; Forstner G; Levison H
    J Pediatr; 1989 Aug; 115(2):274-7. PubMed ID: 2754556
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
    Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
    Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis.
    Couper RT; Corey M; Durie PR; Forstner GG; Moore DJ
    J Pediatr; 1995 Sep; 127(3):408-13. PubMed ID: 7658271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related alterations in immunoreactive pancreatic lipase and cationic trypsinogen in young children with cystic fibrosis.
    Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
    J Pediatr; 1985 Sep; 107(3):377-81. PubMed ID: 4032133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malabsorption of crystalline vitamin B 12 in cystic fibrosis.
    Deren JJ; Arora B; Toskes PP; Hansell J; Sibinga MS
    N Engl J Med; 1973 May; 288(18):949-50. PubMed ID: 4693247
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening.
    Sontag MK; Corey M; Hokanson JE; Marshall JA; Sommer SS; Zerbe GO; Accurso FJ
    J Pediatr; 2006 Nov; 149(5):650-657. PubMed ID: 17095337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of endogenous and exogenous functions of the pancreas and blood lipid spectrum in children with mucoviscidosis].
    Turkina TI; Kapranov NI; Ageĭkin VA; Kashirskaia NIu
    Pediatriia; 1989; (12):85-6. PubMed ID: 2628919
    [No Abstract]   [Full Text] [Related]  

  • 8. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program.
    Waters DL; Dorney SF; Gaskin KJ; Gruca MA; O'Halloran M; Wilcken B
    N Engl J Med; 1990 Feb; 322(5):303-8. PubMed ID: 2296272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of the exocrine pancreas in cystic fibrosis.
    Durie PR; Forstner GG
    J R Soc Med; 1989; 82 Suppl 16(Suppl 16):2-10. PubMed ID: 2657051
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluorescein dilaurate test of exocrine pancreatic function in cystic fibrosis.
    Dalzell AM; Heaf DP
    Arch Dis Child; 1990 Jul; 65(7):788-9. PubMed ID: 2386387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of the pancreas in cystic fibrosis.
    Durie PR
    Neth J Med; 1992 Oct; 41(3-4):97-100. PubMed ID: 1470291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic function testing in cystic fibrosis.
    Durie PR; Gaskin KJ; Corey M; Kopelman H; Weizman Z; Forstner GG
    J Pediatr Gastroenterol Nutr; 1984; 3 Suppl 1():S89-98. PubMed ID: 6502397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of secretine sniff on exocrine pancreatic function in cystic fibrosis (author's transl)].
    Hottinger S; Biland F; Bender S; Hadorn B
    Schweiz Rundsch Med Prax; 1975 Sep; 64(38):1209-13. PubMed ID: 1178645
    [No Abstract]   [Full Text] [Related]  

  • 14. Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency.
    Couper RT; Corey M; Moore DJ; Fisher LJ; Forstner GG; Durie PR
    Pediatr Res; 1992 Aug; 32(2):179-82. PubMed ID: 1508606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.
    Durie PR; Forstner GG; Gaskin KJ; Moore DJ; Cleghorn GJ; Wong SS; Corey ML
    Pediatr Res; 1986 Mar; 20(3):209-13. PubMed ID: 3703609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic and intestinal dysfunction in cystic fibrosis.
    Forstner GG; Kopelman HR; Durie PR; Corey ML
    Prog Clin Biol Res; 1987; 254():7-17. PubMed ID: 3432303
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology of the pancreatic defect in Johanson-Blizzard syndrome: a disorder of acinar development.
    Jones NL; Hofley PM; Durie PR
    J Pediatr; 1994 Sep; 125(3):406-8. PubMed ID: 8071749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exocrine pancreatic function in cystic fibrosis.
    Guy-Crotte O; Carrère J; Figarella C
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):755-9. PubMed ID: 8864671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis.
    Moore DJ; Forstner GG; Largman C; Cleghorn GJ; Wong SS; Durie PR
    Gut; 1986 Nov; 27(11):1362-8. PubMed ID: 3792918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiopathology of pancreatic involvement in cystic fibrosis].
    Guy-Crotte O; Carrère J; Figarella C
    Pathol Biol (Paris); 1991 Jun; 39(6):631-5. PubMed ID: 1923599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.